cGMP Protein and Antibody Purification

KBI Biopharma has extensive experience developing purification processes for a wide variety of biotherapeutics, including: -Monoclonal antibodies-Bispecific antibodies -Enzymes -Fc fusion proteins -PEGylated proteins -Complex glycoproteins KBI supports 40+ annual programs ranging from FIH (First-in-Human) process development to late-stage process development, characterization, and validation. 15+ IND submissions are supported annually. By leveraging experience gained from developing processes for over 75 biomolecules, KBI has perfected standard approaches for developing processes for various classes of proteins, including monoclonal antibodies. This experience has also allowed KBI to develop a toolbox that promptly resolves unique protein purification challenges.